JONES FINANCIAL COMPANIES LLLPJONES FINANCIAL COMPANIES LLLP

Institutional investor · Portfolio as of Q2 2020

SEC EDGAR SourceSEC Filings

Top Holdings192 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
VTVVTV
ETF

VANGUARD VALUE ETF

75.8M$7.3B16.0%$82.61+4.27%
7 qtrssince 2018-Q4
Decreased
0
AGGAGG
ETF

ISHARES TR

49.1M$5.8B12.6%$85.79+14.73%
7 qtrssince 2018-Q4
Decreased
0
BNDBND
ETF

VANGUARD TOTAL BOND MARKET

31.8M$2.8B6.1%$63.12+15.83%
7 qtrssince 2018-Q4
Decreased
0
VUGVUG
ETF

VANGUARD GROWTH ETF

13.1M$2.6B5.6%$25.40+28.17%
7 qtrssince 2018-Q4
Increased
88
IEFAIEFA
ETF

ISHARES CORE MSCI EAFE ETF

44.8M$2.5B5.6%$48.76-0.81%
7 qtrssince 2018-Q4
Decreased
0
VEAVEA
ETF

VANGUARD FTSE DEVELOPED ETF

64.7M$2.5B5.4%$30.05+8.39%
7 qtrssince 2018-Q4
Decreased
0
VVVV
ETF

VANGUARD LARGE-CAP ETF

17.6M$2.4B5.3%$106.09+23.08%
7 qtrssince 2018-Q4
Increased
68
VBVB
ETF

VANGUARD SMALL-CAP VIPERS

12.8M$1.8B3.9%$118.01+12.40%
7 qtrssince 2018-Q4
Decreased
0
VEUVEU
ETF

VANGUARD FTSE ALL-WORLD EX-U

31.4M$1.5B3.2%$37.26+7.58%
7 qtrssince 2018-Q4
Increased
60
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

13.3M$1.5B3.2%$95.18+5.10%
7 qtrssince 2018-Q4
Decreased
0
EFVEFV
ETF

ISHARES MSCI EAFE VALUE ETF

32.8M$1.3B2.8%$33.19-4.01%
7 qtrssince 2018-Q4
Increased
78
IWBIWB
ETF

ISHARES RUSSELL 1000 ETF

6.5M$1.1B2.4%$129.51+21.54%
7 qtrssince 2018-Q4
Decreased
0
VBRVBR
ETF

VANGUARD SMALL-CAP VALUE ETF

10M$1B2.2%$96.04-2.00%
7 qtrssince 2018-Q4
Decreased
0
IJSIJS
ETF

ISHARES S&P SMALL-CAP 600 VA

7.4M$837.9M1.8%$57.21-4.85%
7 qtrssince 2018-Q4
Decreased
0
VOVO
ETF

VANGUARD MID-CAP ETF

4.9M$775.2M1.7%$32.21+16.17%
7 qtrssince 2018-Q4
Decreased
0
IWMIWM
ETF

ISHARES RUSSELL 2000 ETF ETF

5.3M$729M1.6%$121.92+8.11%
7 qtrssince 2018-Q4
Decreased
0
IVWIVW
ETF

ISHARES S&P 500 GROWTH ETF

3.3M$663.6M1.4%$35.20+39.47%
7 qtrssince 2018-Q4
Decreased
0
IWSIWS
ETF

ISHARES RUSSELL MIDCAP VALUE INDEX FUND

8.4M$623.4M1.4%$66.77+3.11%
7 qtrssince 2018-Q4
Decreased
0
EFGEFG
ETF

ISHARES MSCI EAFE GROWTH ETF

7.3M$608.9M1.3%$69.06+10.21%
7 qtrssince 2018-Q4
Increased
50
VSSVSS
ETF

VANGUARD FTSE ALL WO X-US SC

6.1M$577.9M1.3%$76.59+6.03%
7 qtrssince 2018-Q4
Decreased
0
$45.8B
AUM
192
Positions
Q2 2020
Filing
Rating · 3.0
Quarterly Portfolio Change
+8%Q1'19$43.6B+2%Q2'19$44.5B+2%Q3'19$45.3B+10%Q4'19$50B-17%Q1'20$41.5B+10%Q2'20$45.8B
Activity profile
$ moved · Q2'20
New0%Increased61%Decreased39%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q2%1-4Q7%1-2Y90%2Y+1%

JONES FINANCIAL COMPANIES LLLP manages $45.8B across 192 positions as of Q2 2020. Top holdings: VTV (16.0%), AGG (12.6%), BND (6.1%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 3/5.0.

Q2 2020 Summary

Active quarter - 8 new positions, 10 exits, 68 increased. Top move: VUG (INCREASED, conviction 88). Portfolio: $45.8B across 192 positions.

Top holdings by portfolio weight

Total AUM$46B
VTV16.04%
AGG12.64%
BND6.12%
VUG5.59%
IEFA5.56%
VEA5.43%
VV5.33%
VB3.92%
VEU3.25%
IWD3.18%
Other2.83%

Portfolio allocation by GICS sector

Sectors11
Unknown98.61%
Financial Services0.26%
Technology0.23%
Healthcare0.21%
Communication Services0.14%
Consumer Cyclical0.13%
Consumer Defensive0.12%
Industrials0.12%
Utilities0.05%
Energy0.05%
Other0.08%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track Record49
Conviction44
Concentration70
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
EQLEQLALPS ETF TR
Q3 2024 Q2 2026+60,127 shares+$3M
8Q
IDOGIDOGALPS ETF TR
Q3 2024 Q2 2026+106,073 shares+$4.4M
8Q
BFORBFORALPS ETF TR
Q3 2024 Q2 2026+86,035 shares+$8.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used